E13.43 (Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy) compared with K31.A0 (Gastric intestinal metaplasia, unspecified), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Distinct conditions — both may be reported.
“diabetic gastroparesis (E08.43, E09.43, E10.43, E11.43, E13.43)”
An Excludes2 note means the excluded condition is not part of the code above it, but a patient can have both. Report both when both are documented.
Source: CMS ICD-10-CM tabular instructional notes
Yes, when both are documented. K31.A0 carries an Excludes2 note covering E13.43: “diabetic gastroparesis (E08.43, E09.43, E10.43, E11.43, E13.43)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
| E13.43Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy | K31.A0Gastric intestinal metaplasia, unspecified | |
|---|---|---|
| Billing status | Billable | Billable |
| Classification | E00-E89 — Endocrine, Nutritional and Metabolic Diseases (E00-E89) | K00-K95 — Diseases of the Digestive System (K00-K95) |
| Definition | Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy is a billable ICD-10-CM diagnosis code (E13.43). | Gastric intestinal metaplasia, unspecified is a billable ICD-10-CM diagnosis code (K31.A0). |
| Includes | diabetes mellitus due to genetic defects of beta-cell function diabetes mellitus due to genetic defects in insulin action postpancreatectomy diabetes mellitus postprocedural diabetes mellitus | functional disorders of stomach Gastric intestinal metaplasia indefinite for dysplasia Gastric intestinal metaplasia NOS |
| Use additional code | code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85) insulin (Z79.4) | — |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources